- Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterolog y 1996;111:1683-99.
- Salzmann JL, Peltier-Koch F, Bloch F, Petite JP, Camilleri JP. Methods in laboratory investigation: morphometric study of colonie biopsies. A new method of estimating inflammatory diseases. Lab Invest 1992;60:847-51.
- Lindberg G, Glia A, Nyberg B, Veress B. Lymphocytic epithelioganglionitis-a new entity causing severe motility disorders of the gut [Abstract]. Gastroenterolog y 1999:G4476.
- Lennon VA, Sas DF, Busk MF, Scheithauer B, Malagelada JR, Camilleri M, et al. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterolog y 1991;100:137-42.
- Howe S, Baker EY, Sallustio JE, Peebles C, Tan EM, Williams RC Jr. Antimyenteric neuronal antibodies in scleroderma. J Clin Invest 1994:94:761-70.
- Coin JC, Sterin-Borda L, Bilder CR, Varrica LM, Iantomo G, Rios MC, et al. Functional implications of circulating muscarinic cholinergic receptor autoantibodies in Chagasic patients with achalasia. Gastroenterolog y 1999;117:798-805.
- Smith W, Gregson N, Foggensteiner L, Neale G, Milla PJ. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterolog y 1997:112:1366-71.
- Rose MR. Neurological channelopathies: dysfunctional ion channels may cause many neurological disorders [Editorial]. BMJ 1998;316:1104-5.
- Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Huffman SMG, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996:87:543-52.
- Lang B, Vincent A. Autoimmunity to ion-channels and other proteins in paraneoplastic disorders. Curr Opin Immunol 1996; 8:865-71.
- Vincent A, Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 1985;48:1246-52.
- Meriney SD, Hulsizer SC, Lennon VA, Grinnell AD. LambertBaton myasthemic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma. Ann Neurol 1996;40:739-49.
- Motomura M, Lang B, Johnston I, Palace J, Vincent A, Newsom-Davis J. Incidence of serum anti-P/O-type and antiN-type calcium channel autoantibodies in the Lambert-Eaton myasthénie syndrome. J Neurol Sci 1997;147:35-42.
- Shilito P, Molenaar PC, Vincent A, Leys K., Zheng W, van den Berg RJ, et al. Acquired neuromyotonia : evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 1995;38:714-22.
- Hart IK, Waters C, Vincent A, Newland C, Benson D, Pongs O, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 1997;41:238-46.
- Balestra B, Moretti M, Longhi R, Mantegazza R, dementi F, Gotti C. Antibodies against neuronal nicotinic receptor subtypes are present in patients with neurological disorders. J Neuroimmunol 2000; 102:89-97.
- Vemino S, Adamaski J, Kryzer T, Fealey R, Lennon V. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer related syndromes. Neurology 1998;50:1806-13.
- Pande R, Leis A. Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody. Muscle Nerve 1999;22:1600-2.
- Vincent A, Grimaldi LME, Martino G, Davenport C, Todd I. Antibodies to 125I-glutamic acid decarboxylase in patients with stiff man syndrome. J Neurol Neurosurg Psychiatry 1997;62: 395-7.
- Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA, et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990;323:1167-72.
- Castle NA, Haylett DG, Jenkinson DH. Toxins in the characterisation of potassium channels. TINS 1989;12:59-65.
- Toyka KV, Brachman DB, Pestronk A, Kao I. Myasthenia gravis: passive transfer from man to mouse. Science 1975;190: 397-9.
- Newsom-Davis J, Pinching AJ, Vincent A, Wilson SG. Function of circulating antibody to acetylcholine receptor in my asthenia gravis: investigation by plasma exchange. Neurology 1978;28: 266-72.
- Knowles CH, Scott SM, Williams NS, Lunniss PJ. Clinical and physiological heterogeneity in slow transit constipation: a review of 122 patients. Colorectal Dis 2000;2:212-9.
- Preston DM, Lennard-Jones JE. Severe chronic constipation of young women: 'Idiopathic slow transit constipation'. Br J Surg 1986;27:41-8.
- Drossman DA. The functional gastrointestinal disorders and the Rome D process. Gut 1999;45 Suppl 2:111-5.
- Martin JE, Smith W, Domizio P. Myopathies of the gastrointestinal tract. In: Lowe J, Underwood JC, editors. Recent advances in histopathology 18. Edinburgh: Churchill Livingstone; 1999. p. 43-62.
- Gerl A, Storck M, Schaltern A, Müller-Höcker J, Jauch KW, Schildberg FW, et al. Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoid. Gut 1992;33:1000-3.
- Waterman SA, Lang B, Newsom-Davis J. Effect of LambertEaton myasthenic syndrome antibodies on autonomie neurons in the mouse. Ann Neurol 1997;42:147-56.
- Isaacs H. Syndrome of continuous muscle-fiber activity. J Neurol Neurosurg Psychiatry 1961;24:319-25.
- Trivedi R, Mundanthananam G, Amyes E, Lang B, Vincent A. Autoantibody screening in subacute cereballar ataxia. Lancet 2000;356:565-6.
- Lencer WI, Alper SL. The potassium channel and how it works. Gastroenterology 1999; 116:216-7.
Scandinavian Journal of Gastroenterology
Volume 37, 2002 - Issue 2